Page 1

OCTOBER 2014 VOL 3 • NO 5

www.ValueBasedRheumatology.com

RHEUMATOLOGY CENTER PROFILE

THE Rheumatology NURSE™

A conversation with Clifton O. Bingham III, MD, Director, Johns Hopkins Arthritis Center

By Deanna L. Owens, MSN, RN, and Sheree C. Carter, PhD, RN Ms Owens is Director, Infusion and Clinical Services, Low Country Rheumatology, Charleston, SC; and Member, Board of Directors, Rheumatology Nurses Society

Joining the Race to Patient Care, Research, and Rheumatology: RNS Education Are the Pillars of Johns Hopkins Arthritis Center Conference Highlights Louisville, KY—Rheumatology nurses and healthcare providers gathered from across the United States, Canada, Puerto Rico, and Kenya to “Join the Race to Rheumatology” at the 7th Annual Rheumatology Nurses Soci-

ety (RNS) Conference. The conference —which had the largest attendance in the or­ganization’s history—provided networking opportunities and inspired rheumatology nurses to achieve excellence in the care of the Continued on page 19

I

n a recent interview with ValueBased Care in Rheumatology, Clifton O. Bingham III, MD, Associate Professor of Medicine, Division of Rheumatology, and Director of

the Johns Hopkins Arthritis Center, discussed current trends in rheumatology and the pillars of care at Johns Hopkins. The Arthritis Center consists of Continued on page 17

Disease Activity Linked to Radiographic Progression in Ankylosing Spondylitis

Better Osteoporosis Screening Needed for Women Age 50-54 Years By Rosemary Frei, MSc Houston, TX—The US Preventive Services Task Force strategy captures less than 5% of postmenopausal women 50 to 54 years of age who will have a major osteoporotic fracture (MOF) within the next 10 years, according to an analysis presented at the American

Society for Bone and Mineral Research 2014 Annual Meeting. The US Task Force recommends that women younger than 65 years of age should be screened for osteoporosis if their Fracture Risk Assessment Tool (FRAX) score indicates Continued on page 8

By Leslie Wyatt

T

he association between inflammation and new bone formation in ankylosing spondylitis (AS)

has been widely studied and debated in recent years. However, the studies have resulted in inconclusive data

Continued on page 8

INSIDE VALUE PROPOSITIONS. . . . . . . . . . . Behavioral therapy cost-effective in patients with fibromyalgia HEALTH ECONOMICS. . . . . . . . . . . . . Shifts to value-based care and payment models improve quality of care

6

RHEUMATOLOGY UPDATE. . . . 19 Neurologic symptoms of rheumatologic conditions elucidated

9

RHEUMATOID ARTHRITIS . . . . 22 Concomitant use of statins does not significantly impact the efficacy of rituximab

GOUT. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Febuxostat safe and effective in elderly women with hyperuricemia

PERSONALIZED MEDICINE in Rheumatology™. . . . . . . . . . . . . . . . . . . . 26 Autoantibodies in patients with RA could lead to more precise diagnosis, therapy

PSORIATIC ARTHRITIS. . . . . . . . . . . Brodalumab shows positive results in phase 2 trial

© 2014 Engage Healthcare Communications, LLC

6

Profile for Value-Based Cancer Care

Value-Based Care in Rheumatology October 2014  

Value-Based Care in Rheumatology October 2014  

Profile for vbcc
Advertisement